Varian Medical Systems Receives FDA 510(k) Clearance for RapidArc(TM) Radiotherapy ...( Groundbreaking technology delivers f...),Health
Navigation Links
Varian Medical Systems Receives FDA 510(k) Clearance for RapidArc(TM) Radiotherapy Technology
Date:1/3/2008
Groundbreaking technology delivers faster, more precise cancer treatments
using a unique form of volumetric arc therapy
PALO ALTO, Calif., Jan. 2 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) has received FDA 510(k) clearances for its RapidArc(TM) radiotherapy technology, a revolutionary advance that makes it possible to deliver image-guided, intensity-modulated radiation therapy (IMRT) two to eight times faster and more precisely than is possible with conventional IMRT or helical tomotherapy.
"RapidArc represents a major medical advance that will change the way radiation therapy is planned and delivered," says Dow Wilson, president of Varian's Oncology Systems business. "Our primary goal with this product is to improve clinical outcomes. In addition, we discovered that we could simultaneously improve treatment efficiency significantly. RapidArc should make better-quality radiotherapy a more affordable, more accessible treatment option, and enable more cancer patients to receive a higher standard of care."
RapidArc, Varian's new technology for delivering volumetric modulated arc therapy, quickly delivers a complete IMRT treatment in a single rotation of the treatment machine around the patient. The two FDA clearances for RapidArc cover the treatment hardware and the RapidArc treatment planning software module in Varian's Eclipse(TM) treatment planning system. Varian will begin taking orders for RapidArc immediately, and will begin delivering it to customers in the spring of 2008.
"Customer interest in RapidArc is tremendous," said Wilson. "This
technology extends the versatility of Varian's image-guided radiotherapy
system, adding volumetric arc therapy to other advanced capabilities
'/>"/>
| SOURCE Varian Medical Systems Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Cranberry Could Juice Up Ovarian Cancer Treatment
2. New Ovarian Cancer Drug Trial Under Way
3. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
4. Pelvic Exams Can Help Spot Ovarian Cancer
5. Study fuels debate over whether exercise and body size influence ovarian cancer risk
6. Experimental drug boosts survival in recurrent ovarian cancer
7. New Ovarian Cancer Biomarker Research Act Introduced
8. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
9. More Fiber, Less Fat Help Prevent Ovarian Cancer
10. Media availability: low-fat dietary pattern may lower risk of ovarian cancer
11. The Silent Killer, Ovarian Cancer on Your Cancer Today (TM)
Post Your Comments:
(Date:12/2/2009)...aving angioplasty within 90 minutes of hospital ar... (HealthDay News) -- A nationwide program to get f...nd of heart attack has dramatically reduced the ti...asty. , More than three-quarters of people with...lectrocardiogram pattern that shows major blockage...
(Date:12/2/2009)...ally likely to have metabolic syndrome, study find... -- Exercise alone isn,t enough to keep overweight...k for a medical condition that can lead to heart d...died linemen at Division I colleges and found that...etabolic syndrome, a group of conditions that rais...
(Date:12/2/2009)...ADENA, Calif., Dec. 2 H...eceived the Gold Seal of Approval from the Joint C...ke center. This means Huntington will join the ne...hout Los Angeles County. ,, "This is a signif...nt, a wonderful benefit for Pasadena and its surro...
(Date:12/2/2009)...HITE PLAINS, N.Y., Dec. 2 /PRNewswire-USNewswire/ ...their findings in blood cancer research at the ann...e in New Orleans December 4-8, 2009. ,, Throug...ma Society (LLS) experts, including Chief Medical ...sident of Patient Services Hildy Dillon, and Vice ...
(Date:12/2/2009)... ,, NEW YORK, Dec. 2 Care ...ve care coordination, Advanced Illness Coordinate...zations in the last years of life as well as impro...y caregivers without increasing mortality. These a... in American Journal of Managed Care (November 2...
Breaking Medicine News(10 mins):Health News:Heart Attack Treatment Speeds Up Nationwide 2Health News:Heart Attack Treatment Speeds Up Nationwide 3Health News:Oversized College Football Players May Face Heart Risks 2Health News:Huntington Hospital Earns Designation as Primary Stroke Center 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 3Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 4[0] Heart Attack Treatment Speeds Up Nationwide[0] Oversized College Football Players May Face Heart Risks[2] Huntington Hospital Earns Designation as Primary Stroke Center[1] The Leukemia & Lymphoma Society Available to Comment on Findings Presented at American Society of Hematology Conference[0] Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care
... according to television satirist Stephen Colbert,...uition despite the presence of facts or evidence. ...estion, the more likely an individual will believe...is McKinstry found when they asked college student...
...24 Proceeds will benefit Children,s,HeartLink (R)...pler between,Feburary 3 and February 29., "One in...t defect and,one- third of those children will die...butes to our goals of mobilizing,more resources, b...
...4th January 2008 - The main regulators of the immu...e highly involved in a large range of immune disea...acity seems to play a critical role in the onset o... Research Institute of the McGill University Healt...
...st addition to the Connecting for Health Common Fr...tication and call on National,Institute of Standar...ng,practices, WASHINGTON, Jan. 24 The critical c...h of new,electronic health services and personal h...
...orates with the nation,s leading all-women,s event...lifestyle, NEW YORK, Jan. 24 Aflac (NYSE: AFL )... Girl. With 10 events nationwide, ranging,from 5K/...ment to this partnership, the iconic,Aflac Duck an...
... discovered that PM/Scl-75, one of the components ... a cell dies. Finally, Schilders has identified an...y recognised by antibodies. These antibodies possi...mune system has been disrupted to such an extent t...
Other Medicine News:Health News:Children's HeartLink(R) to Benefit From Sales of Kim & Scott's Gourmet Pretzels(R) Valentine's Day Love Knot Sampler(TM) 2Health News:Deficient regulators in the immune system responsible for type 1 diabetes 2Health News:Health and Technology Leaders Tackle Challenge of Managing Consumers' Identities in Web-Based Personal Health Tools 2Health News:Health and Technology Leaders Tackle Challenge of Managing Consumers' Identities in Web-Based Personal Health Tools 3Health News:Health and Technology Leaders Tackle Challenge of Managing Consumers' Identities in Web-Based Personal Health Tools 4Health News:Aflac to Sponsor Iron Girl 2Health News:Aflac to Sponsor Iron Girl 3Unanimous union: The mind and body together lean toward 'truthiness'Children's HeartLink(R) to Benefit From Sales of Kim & Scott's Gourmet Pretzels(R) Valentine's Day Love Knot Sampler(TM)Deficient regulators in the immune system responsible for type 1 diabetesHealth and Technology Leaders Tackle Challenge of Managing Consumers' Identities in Web-Based Personal Health ToolsAflac to Sponsor Iron GirlChopped up proteins trigger autoimmunity
(Date:12/2/2009)... , LAKE FOREST, Ill., Dec. 2 /PRNewswire-Fir... provider of clinical information and medication d...acquired Salt Lake City-based TheraDoc, a clinical...llance systems. TheraDoc,s two leading products, I...stant(TM), join Hospira,s expanding portfolio of m...
(Date:12/2/2009)..., PHILADELPHIA, Pennsylvania, December 2 /P...Q: SHPGY ), the global specialty biopharmaceutica...ation with Teva,Pharmaceuticals USA, Inc. ("Teva")...ric version of ADDERALL XR. Shire has been supplyi...April 1, 2009. Shire,s ability to supply,the produ...
(Date:12/2/2009)... , NEW YORK, Dec. 2 ...day announced that the U.S. Food and Drug Administ...r KRX-0401 (perifosine), the Company,s novel, pote...t inhibits the phosphoinositide 3-kinase (PI3K)/Ak...y multiple myeloma. ,, The Fast Track program...
Breaking Medicine Technology:Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 2Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 3Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 4Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 5Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Minnesota Health Improvement Leaders Honored 56064 1Minnesota Health Improvement Leaders Honored 56064 2Minnesota Health Improvement Leaders Honored 56064 3Lord Stevens Commission Publishes Roadmap to Ensure Future of Equestrian Sport 56062 1Lord Stevens Commission Publishes Roadmap to Ensure Future of Equestrian Sport 56062 2Lord Stevens Commission Publishes Roadmap to Ensure Future of Equestrian Sport 56062 3Obamas Specific Healthcare Speech 3A Will He Disavow Pledge Breaking Tax Hikes in House Dem Health Bill 3F 56060 1Obamas Specific Healthcare Speech 3A Will He Disavow Pledge Breaking Tax Hikes in House Dem Health Bill 3F 56060 2[0] Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings[0] Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic[0] Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma
...nt with chemotherapy and pegylated enzyme produces...emotherapy alone - - Pegylated en...me Therapeutics,Inc. (Nasdaq: HALO ), a biopharma...oducts targeting the extracellular matrix, today,a... animal efficacy data,for its pegylated-rHuPH20 en...
...France, July 22 NicOx S.A.,(Euronext Paris: COX) ...enrollment of 417 osteoarthritis (OA) patients wit...logy studies in the United States, in line with,pr...igned to assess the,blood pressure profile of napr...using the Ambulatory Blood Pressure Monitoring (AB...
Other Medicine Technology:Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |